CANbridge Life Sciences, a Beijing, China-based clinical-stage biopharmaceutical company focused on developing Western drug candidates in China and North Asia, raised $25m in Series B funding.
Yixin Capital Limited, a Chinese online automotive transaction platform, is to receive an equity investment of up to RMB4 billion.
Palo Alto, CA-based venture capital firm Xiang He Partners raised $261m for its inaugural fund.
WuXi Nextcode, a Shanghai, China- Cambridge, Massachusetts- and Reykjavik, Iceland-based contract genomics organization (CGO) building a global standard platform for genomic data, closed a $75m Series B financing.
Cheetah Mobile Inc. (NYSE: CMCM), a Beijing, China-based mobile internet company, is to raise an aggregate of US$60m.
Didi Chuxing, a Chinese taxi hailing company, raised US$5.5 billion round of funding.
Changzhou National Hi-Tech District, one of China’s leading high-tech industrial development zones located in the Yangtze River Delta, and Shenzhen Capital Group Co., Ltd., a venture capital firm specializing in seed, early stage and later stage investments, signed a strategic cooperation agreement to enhance resource integration and jointly set up a new talent investment fund.
UniFi‘s parent company Shanghai Wheat Asset Management Co., Ltd., a Shangai, China-based Internet-based financial information service provider, received a Series B funding round of undisclosed amount.
EpimAb Biotherapeutics, a Shanghai, China-based biopharmaceutical company specializing in bispecific antibodies, closed a $25m Series A funding.
IceKredit Inc., a Shanghai, China-based provider of a credit assessment platform, raised US$16m in series A funding.
Microvast Power System, a Chinese developer and manufacturer of advanced Electric Vehicle Power System solutions and subsidiary of Microvast, received $400m in funding.
Wecash, a Beijing, China-based fintech company, closed US$80M in Series C funding.
NetEase Cloud Music, a Chinese online music platform, raised RMB 750 million (approx. USD$108m) in Series A funding.
GeneQuantum Healthcare (Suzhou) Co., Ltd., a Suzhou, China-based company focused on the research and development of innovative bio-therapeutics, completed an RMB40m (approx. $5.8m) Series A financing.
GPA Global, a specialty packaging and display solutions provider, received an equity investment from EQT Mid Market.